Smokers who have difficulty falling asleep at night may find it doubly hard to stop smoking, a study suggests. At the same time, non-insomniac smokers may develop symptoms of sleeplessness if they continue using tobacco.
Frontline healthcare workers who are directly diagnosing, treating, or caring for patients with COVID-19 have increased risks for depression, anxiety, insomnia, and distress, according to a study from China.
Dr Poon Shi Hui, a consultant at the Department of Psychiatry at Singapore General Hospital, speaks to Roshini Claire Anthony on the different types of insomnia and the various management strategies deployed for each type.
The dual orexin receptor antagonist lemborexant effectively promotes sleep by improving both the onset and maintenance of sleep compared with placebo or zolpidem in older patients with insomnia, the SUNRISE 1* trial has shown.
New drug applications approved by US FDA as of 16 - 31 December 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Routine prescription of a hypnotic medication does not appear to substantially reduce suicidal ideation in depressed outpatients with insomnia, but coprescription of such drug during antidepressant initiation may help suicidal outpatients, particularly those with severe insomnia, suggest the results of a study.
Fibromyalgia patients with comorbid insomnia more often receive prescription medications for fibromyalgia and use ambulatory care services relative to their counterparts without the sleep disorder, according to a study, suggesting that comorbidity with insomnia substantially increases its burden.
Use of opioid pain medication among adults with comorbid symptoms of insomnia and chronic pain appears to prolong time spent being awake in bed, reports a study, adding that such effect cannot be attributed to changes in pain, use of sleep medication or total sleep time.
Guided online Cognitive Behavioral Therapy for Insomnia (CBT-I) may be used in the management of both insomnia and depressive symptoms, with effect sizes being large and comparable to that of depression therapy, according to a study.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Psychiatry - Malaysia digital copy today!
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.